2483.8000 27.90 (1.14%)
NSE Jan 02, 2026 15:31 PM
Volume: 27,469
 

2483.80
1.14%
ICICI Securities Limited
GlaxoSmithKline Pharmaceuticals’ (GSK) Q1FY25 result was ahead of our expectations driven by mixed improvement and curb in overhead cost.
GlaxoSmithKline Phar.. has an average target of 2750.00 from 2 brokers.
More from GlaxoSmithKline Pharmaceuticals Ltd.
Recommended